인트로메딕 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 김현서, was filed 10 Dec 2024.
인트로메딕: what insiders have been doing
인트로메딕 is a Health Care company. Its directors and officers file their transactions with DART (FSS). Between 10 November 2025 and 10 November 2026, 1 insider published 1 filing.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 2,648 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 3 purchases and no sales.
No insider has bought 인트로메딕 shares on the open market in the past twelve months.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleFinancial data
· cache
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 105,289 sharesShareKRXDART:20241210000545Canonical exit: 10 Mar 2025 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ShareKRXDART:20210430000986Canonical exit: 29 Jul 2021 (T+90)
- ●Executives0DART
- ShareKRXDART:20210426000452Canonical exit: 25 Jul 2021 (T+90)
- ●Executives0DART
18 of 18 declarations
About 인트로메딕
인트로메딕 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative medical technologies.
